Filtrera efter Last updated date SelectEfterFöreFrom - To Date Slutdatum Denna vecka Den här månaden Förra veckan Förra månaden Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Lämna detta fält tomt Filter Resultat (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Lämna detta fält tomt COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines 4 maj 2020Press releaseHumanCOVID-19MedicinesResearch and developmentVaccines Regulatory flexibility to ensure availability of veterinary medicines during COVID-19 pandemic 4 maj 2020NewsVeterinaryCOVID-19Regulatory and procedural guidanceMedicine shortages EMA starts rolling review of remdesivir for COVID-19 30 april 2020Press releaseHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020 30 april 2020NewsHumanMedicinesReferrals Suspension of ranitidine medicines in the EU 30 april 2020Press releaseHumanPharmacovigilanceQuality of medicinesReferrals EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine 30 april 2020Press releaseHumanPharmacovigilanceReferrals First triple combination therapy for asthma with optional electronic sensor 30 april 2020Press releaseHumanMedicines Risks of Picato for actinic keratosis outweigh benefits 30 april 2020Press releaseHumanMedicinesReferrals EU actions to support availability of medicines during COVID-19 pandemic – update #4 30 april 2020Press releaseHumanCOVID-19Medicine shortages International regulators pledge collective support to combat COVID-19 pandemic 28 april 2020NewsHumanCOVID-19 1 … 86 87 88 89 90 Page 90 of 383 91 92 93 94 … 383
COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines 4 maj 2020Press releaseHumanCOVID-19MedicinesResearch and developmentVaccines
Regulatory flexibility to ensure availability of veterinary medicines during COVID-19 pandemic 4 maj 2020NewsVeterinaryCOVID-19Regulatory and procedural guidanceMedicine shortages
EMA starts rolling review of remdesivir for COVID-19 30 april 2020Press releaseHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020 30 april 2020NewsHumanMedicinesReferrals
Suspension of ranitidine medicines in the EU 30 april 2020Press releaseHumanPharmacovigilanceQuality of medicinesReferrals
EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine 30 april 2020Press releaseHumanPharmacovigilanceReferrals
First triple combination therapy for asthma with optional electronic sensor 30 april 2020Press releaseHumanMedicines
Risks of Picato for actinic keratosis outweigh benefits 30 april 2020Press releaseHumanMedicinesReferrals
EU actions to support availability of medicines during COVID-19 pandemic – update #4 30 april 2020Press releaseHumanCOVID-19Medicine shortages
International regulators pledge collective support to combat COVID-19 pandemic 28 april 2020NewsHumanCOVID-19